THC drug
Evidence from:
primary |
all sources
Related entities (39)
Mentioned in (30)
Papers in which this entity is mentioned.
- Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
- Multifactorial Genetic and Environmental Hedgehog Pathway Disruption Sensitizes Embryos to Alcohol-Induced Craniofacial Defects. (2020)
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction. (2019)
- Sex-dependent effects of in utero cannabinoid exposure on cortical function. (2018)
- The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (2018)
- Does puberty mark a transition in sensitive periods for plasticity in the associative neocortex? (2017)
- The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a translational study. (2017)
- Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States. (2016)
- Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (2015)
- Genome-Wide DNA Methylation Profiling Reveals Epigenetic Changes in the Rat Nucleus Accumbens Associated With Cross-Generational Effects of Adolescent THC Exposure. (2015)
- Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure. (2015)
- Prenatal exposure to cannabinoids evokes long-lasting functional alterations by targeting CB1 receptors on developing cortical neurons. (2015)
- Simultaneous versus concurrent use of alcohol and cannabis in the National Alcohol Survey. (2015)
- Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. (2015)
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (2014)
- Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? (2014)
- Neuronal substrates and functional consequences of prenatal cannabis exposure. (2014)
- Cannabis controversies: how genetics can inform the study of comorbidity. (2014)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- A survey of synthetic cannabinoid consumption by current cannabis users. (2014)
- Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. (2013)
- Rethinking schizophrenia in the context of normal neurodevelopment. (2013)
- Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. (2012)
- Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. (2012)
- Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Protein kinases and addiction. (2008)
- EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. (2008)
- The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. (1995)
Merged raw entities (9)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| thc | drug | 30 | 277 |
| δ-9-tetrahydrocannabinol | drug | 1 | 1 |
| 2.78% thc | drug | — | — |
| cb receptor agonist thc | drug | — | — |
| delta (9)-tetrahydrocannabinol | drug | — | — |
| oral synthetic thc | drug | — | — |
| oral thc | drug | — | — |
| thc administration | drug | — | — |
| δ9‑tetrahydrocannabinol | drug | — | — |